首页> 外文期刊>Vaccine >Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions
【24h】

Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions

机译:儿童血清中抗5型腺病毒(Ad5)和41型病毒(Ad41)的抗体的流行与年龄和卫生状况有关

获取原文
获取原文并翻译 | 示例
           

摘要

Neutralizing antibody (NAb) can dampen the immunogenicity of adenovirus (Ad) vector-based vaccine. Vector systems based on human adenovirus type 41 (Ad41) have been constructed and used to develop recombinant vaccines. Here, we attempted to study the seroprevalence of NAbs to Ad5 and Ad41 among children and adults in Qinghai province, China. The positive rates (titer 40) of Ad5 and Ad41 NAb in adults from Xining city were 75.7% and 94.7%, respectively. The moderate/high-positive rates (titer 160) of NAb were quite close between the two viruses in adults (70.4% for Ad5 and 73.5% for Ad41). Age-dependent increase of NAb seroprevalence was observed for both viruses in children. NAb-positive rate of Ad41 reached 50% at 3.3-4.6 years of age for children from Chengxi district, Xining city, approximately 1.5 years earlier than that of Ad5 did. Interestingly, NAb level was also associated with sanitary conditions among young children. For Ad5, 8-15% children (0.2-3.0 years of age) from city or town, where the sanitations were relatively better, had moderate/high-positive NAb, while the same rate was 62% for children from villages. For Ad41, 22% children from city, 47% from town and 88% from villages possessed moderate/high-positive NAb. The possible influence of NAb titer distributions on the application of Ad41-vectored vaccines was discussed in detail. Our results suggested that children from places with poor sanitations should be included for comprehensive Ad NAb seroprevalence studies, and provided insights to the applications of Ad41 vectors. (C) 2016 Elsevier Ltd. All rights reserved.
机译:中和抗体(NAb)可以减弱基于腺病毒(Ad)载体的疫苗的免疫原性。已经构建了基于人类41型腺病毒(Ad41)的载体系统,并将其用于开发重组疫苗。在这里,我们试图研究中国青海省儿童和成年人中NAbs对Ad5和Ad41的血清阳性率。西宁市成年人Ad5和Ad41 NAb的阳性率(第40位)分别为75.7%和94.7%。在成人的两种病毒之间,NAb的中/高阳性率(滴度160)非常接近(Ad5为70.4%,Ad41为73.5%)。两种病毒在儿童中均观察到年龄依赖性的NAb血清阳性率的升高。西宁市城西区儿童在3.3-4.6岁时,Ad41的NAb阳性率达到50%,比Ad5早1。5年。有趣的是,NAb水平也与幼儿的卫生状况有关。对于Ad5,卫生条件相对较好的城市或城镇中,有8-15%的儿童(0.2-3.0岁)的NAb呈中度/高阳性,而来自乡村的儿童则为62%。对于Ad41,来自城市的22%的儿童,来自城镇的47%的儿童和来自村庄的88%的儿童具有中等/高阳性NAb。详细讨论了NAb效价分布对Ad41载体疫苗的应用的可能影响。我们的结果表明,应将来自卫生条件差的儿童纳入全面的Ad NAb血清阳性率研究中,并为Ad41载体的应用提供见识。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号